Youth-focused group mindfulness-based intervention in individuals with early psychosis: A randomized pilot feasibility study.


Journal

Early intervention in psychiatry
ISSN: 1751-7893
Titre abrégé: Early Interv Psychiatry
Pays: Australia
ID NLM: 101320027

Informations de publication

Date de publication:
08 2019
Historique:
received: 25 02 2018
revised: 12 09 2018
accepted: 22 09 2018
pubmed: 16 10 2018
medline: 26 11 2019
entrez: 16 10 2018
Statut: ppublish

Résumé

To assess the feasibility of a randomized pilot trial that evaluated the acceptability and potential clinical utility of the Mindfulness Ambassador Program (MAP), a unique, standardized 12-session facilitated group mindfulness-based intervention (MBI) for youth experiencing early psychosis. Twenty-one patients of an early psychosis intervention program were randomized to receive MAP (n = 11) or treatment as usual (n = 10). Acceptability was measured by group attendance rate and client satisfaction; feasibility of the study design was measured by the recruitment and retention rate. The means, standard deviations, and 95% confidence intervals were described for outcomes of interest. MAP is associated with a high degree of acceptability and has beneficial effects for depression and fatigue. The randomized trial design is feasible. This study provides important pilot data supporting a larger randomized trial of effectiveness for MAP as a group MBI for early psychosis. Details of MAP and study limitations are discussed.

Identifiants

pubmed: 30318868
doi: 10.1111/eip.12753
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

993-998

Subventions

Organisme : Academic Medical Organization of Southwestern Ontario
ID : Opportunities Fund
Pays : International
Organisme : Lawson Health Research Institute
ID : Internal Research Fund
Pays : International

Informations de copyright

© 2018 John Wiley & Sons Australia, Ltd.

Auteurs

Arlene G MacDougall (AG)

Department of Psychiatry, Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada.
Lawson Health Research Institute, London, Ontario, Canada.
Prevention and Early Intervention Program for Psychoses, London Health Sciences Centre, London, Ontario, Canada.
Department of Epidemiology and Biostatistics, Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada.

Elizabeth Price (E)

Lawson Health Research Institute, London, Ontario, Canada.

Matthew R J Vandermeer (MRJ)

Lawson Health Research Institute, London, Ontario, Canada.

Chantelle Lloyd (C)

Lawson Health Research Institute, London, Ontario, Canada.
Prevention and Early Intervention Program for Psychoses, London Health Sciences Centre, London, Ontario, Canada.

Richelle Bird (R)

Lawson Health Research Institute, London, Ontario, Canada.
Prevention and Early Intervention Program for Psychoses, London Health Sciences Centre, London, Ontario, Canada.

Rickinder Sethi (R)

Department of Psychiatry, Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada.

Aturan Shanmugalingam (A)

Department of Psychiatry, Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada.

Jason Carr (J)

Department of Psychiatry, Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada.
Lawson Health Research Institute, London, Ontario, Canada.

Kelly K Anderson (KK)

Department of Psychiatry, Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada.
Lawson Health Research Institute, London, Ontario, Canada.
Department of Epidemiology and Biostatistics, Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada.

Ross M G Norman (RMG)

Department of Psychiatry, Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada.
Lawson Health Research Institute, London, Ontario, Canada.
Prevention and Early Intervention Program for Psychoses, London Health Sciences Centre, London, Ontario, Canada.
Department of Epidemiology and Biostatistics, Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH